q4

Showing 5 posts of 20 posts found.

Roche image

Oncology drives Roche profits

January 30, 2014
Sales and Marketing Actemra, Perjeta, Roche, Swiss, q4

Sales at Roche’s pharma division rose 7% year-on-year in 2013, driven largely by strong performances from its oncology portfolio. Group …

Sales rise for Novartis

January 30, 2014
Sales and Marketing Gleevec, Glivec, Novartis, gilenya, q4, sales

Multiple sclerosis drug Gilenya, with sales rising 62% year-on-year to $1.9 billion, was one of the stars of last year …

Pfizer image

Profits drop for Pfizer

January 29, 2014
Sales and Marketing Enbrel, Lipitor, Pfizer, Spiriva, Zoetis, q4

Pfizer’s turnover fell to $54.6 billion in 2013, a 6% drop year-on-year from $54.7 billion in 2012, but the group …

BMS image

BMS revenue drops in 2013

January 27, 2014
Sales and Marketing AZ, BMS, Yervoy, diabetes, hep C, q4

Bristol-Myers’ Squibb’s revenue has fallen 7% year-on-year to $16.4 billion during 2013. Turnover rose 6% to $4.4 billion in the …

J&J image

J&J profits up amid drug gains

January 23, 2014
Sales and Marketing FDA, J&J, JJ, Remicade, Zytiga, olysio, q4

Johnson & Johnson’s sales in the fourth quarter of 2013 rose 4.5% compared to the same period in the previous …

The Gateway to Local Adoption Series

Latest content